Speciality: All Speciality
Description:
A warm welcome to all the medical professionals in this interesting session on the benefits of influenza vaccination in high risk populations of diabetes and COPD patients. In this webinar, Dr. Marco Goeijenbier has shared the insights on the benefits of influenza vaccination in high risk populations.
Influenza is responsible for multiple deaths and about 20 to 30% of the deaths occurring annually are observed in children depicting the poor condition of controlling influenza in children. The virus is present globally but is not that powerful to create an epidemic.
Influenza is a contagious infection in nature causing high fever, body aches, cough, and other symptoms. Basically the children suffer for less than a week with the flu, but in cases of serious illness, they may need to be admitted to the hospital.
Among people with diabetes and chronic lung disease like COPD influenza causes severe impacts and flu vaccination has been shown to be associated with reduced hospitalizations from a worsening of their chronic condition. Flu vaccinations can shorten the length of hospital stay due to flu, reduce the risk of ICU admission from flu and also helps in reducing the risk of death from flu.
Therefore, get an overall knowledge regarding the benefits of influenza vaccination in high risk populations of diabetes and COPD patients.
See More Webinars @ Hidoc Webinars
See More Webinars @ Hidoc Webinars
1.
More Positive Survival Data in Lung Cancer With Perioperative Therapy
2.
Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy
3.
Study finds 10% of pediatric blood cancers may stem from medical imaging radiation
4.
For the creation of cutting-edge targeted radionuclide therapies in oncology, Bayer and Bicycle Therapeutics work together.
5.
Pre-operative evaluation of ovarian cancer patients using DWI-MRI is helpful.
1.
Case Study: Artificial Intelligence in Early Cancer Detection
2.
Understanding Acute Intermittent Porphyria: Symptoms, Diagnosis and Treatment
3.
What is Mullerian and How Does it Affect Your Health
4.
AI in Cancer Care: Transforming Research & Treatment with Deep Learning Technologies
5.
Is p53 the Missing Puzzle Piece? Exploring Its Polymorphisms in Cervical Cancer Risk
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Should We Use DARA Up Front As First-Line Therapy in MM?
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
4.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation